Table 2.
Biochemical variables and left ventricular mass of the control group, the group of RA subjects treated with nonbiological DMARDs, and those treated with biological DMARDs.
| Variable | Control group n = 16 |
RA nonbiological DMARDs n = 16 |
RA biological DMARDs n = 18 |
|---|---|---|---|
| Glucose (mg/dL) | 94.87 ± 8.87 | 91.43 ± 16.07 | 86.22 ± 10.37 |
| Basal insulin (mU/mL) | 12.25 ± 6.85 | 13.09 ± 7.92 | 13.32 ± 6.32 |
| Total cholesterol (mg/dL) | 197.43 ± 50.23 | 212.37 ± 48.54 | 197.55 ± 54.70 |
| HDL-C (mg/dL) | 50.53 ± 14.52 | 51.91 ± 15.41 | 55.49 ± 13.47 |
| LDL-C (mg/dL) | 121.24 ± 47.83 | 130.81 ± 36.78 | 118.55 ± 41.86 |
| Non-HDL-C (mg/dL) | 146.90 ± 44.60 | 160.45 ± 47.45 | 142.06 ± 49.90 |
| Triglycerides (mg/dL) | 140.62 ± 54.33 | 148.18 ± 84.75 | 117.66 ± 64.08 |
| Tg/HDL-C ratio | 2.90 ± 1.19 | 3.11 ± 2.26 | 2.24 ± 1.49 |
| hs-CRP (mg/L) | 1.61 ± 0.82 | 2.79 ± 1.51* | 2.76 ± 1.94* |
| LVM (g/m2) | 84.62 ± 26.07 | 130.44 ± 25.77** | 120.94 ± 29.53** |
Continuous variables are presented as X ± SD.
HDL-C: high-density lipoprotein, LDL-C: low-density lipoprotein, Tg: triglycerides, hs-CRP: high-sensitivity C-reactive protein, and LVM: left ventricular mass. * P = 0.033 versus control group. ** P = 0.0001 versus control group.